Galecto Inc
NASDAQ:GLTO
Galecto Inc
Capital Expenditures
Galecto Inc
Capital Expenditures Peer Comparison
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Galecto Inc
NASDAQ:GLTO
|
Capital Expenditures
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Genmab A/S
CSE:GMAB
|
Capital Expenditures
-kr300m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
9%
|
CAGR 10-Years
-38%
|
|
Zealand Pharma A/S
CSE:ZEAL
|
Capital Expenditures
-kr26.2m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-48%
|
CAGR 10-Years
-16%
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
Capital Expenditures
-€1.4m
|
CAGR 3-Years
59%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Capital Expenditures
-kr741.2m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-15%
|
Bioporto A/S
CSE:BIOPOR
|
Capital Expenditures
-kr39k
|
CAGR 3-Years
69%
|
CAGR 5-Years
52%
|
CAGR 10-Years
24%
|
See Also
What is Galecto Inc's Capital Expenditures?
Capital Expenditures
0
USD
Based on the financial report for Dec 31, 2023, Galecto Inc's Capital Expenditures amounts to 0 USD.